NAVMEDCOMINST 6230.2

Question 1

Individuals treated for malaria must wait ____ years from the date treatment was finished until they are eligible to donate blood.

Answer 1

3 years

Question 2

Individuals who were in malaria-risk areas and were required to take chemoprophylaxis because of a perceived risk of exposure must wait ____ years fro the time chemoprophylaxis was finished.

Answer 2

3 years

Question 3

Individuals who visited malaria-risk area and remained asymptomatic, but were not required to take chemoprophylaxis because of negligible risk of exposure must wait how many months to donate blood?

Answer 3

6 months

Question 4

True or False. All Navy, Marine Corps, and MSC personnel must have a documented g6pd test result on their health record

Answer 4

True

Question 5

Any person who is G-6-PD deficient has a risk of hemolysis associated with taking ______ for chemoprophylaxis.

Answer 5

Primaquine

Question 6

Report suspected or confirmed malaria cases in a _____ .

Answer 6

Disease Alert Report. A malaria DAR should include the patient’s itinerary during the previous 3 months and the types and duration of any chemoprophylaxis or treatment medication taken

Question 7

What are the vectors of malaria?

Answer 7

Anopheline mosquito

Question 8

What are the chemoprophylaxis for malaria?

Answer 8

Traditionally, chloroquine and primaquine has been effective. Due to resistance to chloroquine, regimen may require the use of pyrimethamine-sulfadoxine or doxycycline.

Question 9

Since patterns of resistance and drug requirements change frequently, Medical Department of fleet units must contact ______-

Answer 9

NAVENPVNTMEDU prior to deployment to malaria-risk areas

Question 10

What is the Wilson-Edeson Test

Answer 10

Screening test for the presence of chloroquine in the urine. It tests for overall compliance with taking choroquine. 15% false negative rate.

Question 11

The most important aspect of malaria treatment is suspecting this disease in the ________ diagnosis of the patient and beginning immediate treatment.

Answer 11

Differential

Question 12

The types of parenteral antimalarial drugs used to treat severe cases of malaria are:

Answer 12

Parenteral chloroquine hydrochloride, quidine gluconate, and quinine dihydrochloride

Question 13

NAVMEDCOMINST 6230.2 is Malaria prevention and Control

Answer 13

End